SEC Form 4 · accession 0000899243-16-028831
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Radovich
Officer — SVP, Operations
Period of report
Sep 8, 2016
Accepted (ET)
Sep 12, 2016 · 7:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $19.89 | Sep 8, 2016 | A | 25,000 | A | — | Sep 7, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments, with the first installment on December 8, 2016, subject to the recipient's continued service with the Issuer.